Savolitinib vs. Sunitinib in MET-driven PRCC.

SavolitinibOngoingActive not recruitingPhase 3Open NCT03091192 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT03091192 · Trial Tracker · ComplyRx